EU

Showing 15 posts of 252 posts found.

european_commission_web_5

Poland and Slovenia included in US-EU mutual recognition agreement

February 20, 2019
Research and Development EU, GMP, Poland, Slovenia, USA, mutual recognition

Poland and Slovenia have been deemed capable of carrying out Good Manufacturing Practice (GMP) inspections at an equivalent level to …

28246711066_52e38bc591_z

FMD would not apply in case of no-deal Brexit

February 8, 2019
Medical Communications EU, FMD, UK, brexit, falsified medicines

The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …

400 Pfizer employees set to strike over pensions

February 1, 2019
Medical Communications EU, Ireland, Little Island, Pfizer, Ringaskiddy, SITPU, strike

400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …

Novartis warns of huge impact of no-deal Brexit

January 28, 2019
Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …

credit_-_daniel_leal-olivas-afp

EMA approves more new active substances in 2018, but total recommendations fall

January 14, 2019
Sales and Marketing EMA, EU, Europe, drug approvals, pahrma

2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines …

ben_osborne

Pfizer announces new UK Managing Director

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales

New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

December 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …

shire_image

Shire’s Takhzyro scores EU approval in rare genetic disorder hereditary angioedema

December 3, 2018
Sales and Marketing EU, Europe, Shire, Takhzyro, pharma

Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of …

merckwindow_web

MSD chalks up two HIV drug approvals in Europe

November 30, 2018
Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma

MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …

european_commission_web

Mundipharma’s Neulasta biosimilar approved in EU

November 26, 2018
Sales and Marketing Amgen, EU, Europe, Mundipharma, Neulasta, Pelmeg, pharma

Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the European …

novartis_window

Novartis’ gene therapy Luxturna becomes first approved European therapy for vision loss subtype

November 23, 2018
Medical Communications, Sales and Marketing EU, Europe, Luxturna, Novartis, pharma, vision loss

Novartis has revealed that its one-time gene therapy Luxturna (voretigene neparvovec) has been awarded approval by the European Commission to …

lilly_entrance_web

Eli Lilly’s Emgality cleared for treatment of migraine in Europe

November 20, 2018
Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma

Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …

4768764591_9e4f7f0eb8_z

EU rules may be stifling Britain’s biotech industry

November 19, 2018
Sales and Marketing EU, biotech, britain, funding, grants, industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …

The Gateway to Local Adoption Series

Latest content